Inventor · disambiguated record
Xavier Duportet
Also filed as: DUPORTET XAVIER · DUPORTET XAVIER CESAR
23 granted patents·12 pending applications·41 citations·filing 2016–2025
94Inventor score
Top patents by PatentIndex Score
35 records- 0198US11633348B2Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2022·Granted Apr 25, 2023·4 cites·15 claims
- 0297US11541106B2Method for killing bacteria with an engineered postbioticELIGO BIOSCIENCE·Filed 2022·Granted Jan 3, 2023·7 cites·20 claims
- 0396US11078490B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2020·Granted Aug 3, 2021·3 cites·20 claims
- 0495US11746352B2Microbiome modulation of a host by delivery of DNA payloads with minimized spreadELIGO BIOSCIENCE·Filed 2021·Granted Sep 5, 2023·3 cites·10 claims
- 0594US11224621B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2021·Granted Jan 18, 2022·4 cites·19 claims
- 0693US11839645B2Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2022·Granted Dec 12, 2023·1 cites·13 claims
- 0793US11690880B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2022·Granted Jul 4, 2023·3 cites·19 claims
- 0892US10808254B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2019·Granted Oct 20, 2020·4 cites·19 claims
- 0991US11534467B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2022·Granted Dec 27, 2022·1 cites·23 claims
- 1091US11357831B2Sequence-specific antimicrobials by blocking DNA repairPASTEUR INSTITUT·Filed 2019·Granted Jun 14, 2022·4 cites·18 claims
- 1187US11376286B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2021·Granted Jul 5, 2022·1 cites·18 claims
- 1287US2024218380A1Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2024·Application pending·0 cites
- 1384US11124776B2Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereofELIGO BIOSCIENCE·Filed 2019·Granted Sep 21, 2021·2 cites·17 claims
- 1484US10731153B2Recombinases and target sequencesMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted Aug 4, 2020·3 cites·14 claims
- 1582US12214070B2Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2023·Granted Feb 4, 2025·0 cites·15 claims
- 1680US12214022B2Sequence-specific antimicrobials by blocking DNA repairPASTEUR INSTITUT·Filed 2022·Granted Feb 4, 2025·0 cites·16 claims
- 1780US11584918B2Transcriptional control in prokaryotic cells using DNA-binding repressorsELIGO BIOSCIENCE·Filed 2020·Granted Feb 21, 2023·1 cites·19 claims
- 1880US2023330157A1Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2023·Application pending·0 cites
- 1980US2024209326A1Bacterial delivery vehicle, process of production and uses thereofELIGO BIOSCIENCE·Filed 2024·Application pending·0 cites
- 2078US11970716B2Transcriptional control in prokaryotic cells using DNA-binding repressorsELIGO BIOSCIENCE·Filed 2023·Granted Apr 30, 2024·0 cites·25 claims
- 2178US11946056B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2021·Granted Apr 2, 2024·0 cites·15 claims
- 2277US2024218335A1Transcriptional control in prokaryotic cells using dna-binding repressorsEligo Biosciecne·Filed 2024·Application pending·0 cites
- 2373US11952594B2Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereofELIGO BIOSCIENCE·Filed 2021·Granted Apr 9, 2024·0 cites·15 claims
- 2470US12098372B2Microbiome modulation of a host by delivery of DNA payloads with minimized spreadELIGO BIOSCIENCE·Filed 2023·Granted Sep 24, 2024·0 cites·8 claims
- 2569US11905516B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2018·Granted Feb 20, 2024·0 cites·20 claims
- 2668US2023226129A1Elimination of colonic bacterial driving lethal inflammatory cardiomyopathyELIGO BIOSCIENCE·Filed 2023·Application pending·0 cites
- 2766US2025144006A1Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2025·Application pending·0 cites
- 2865US11617773B2Elimination of colonic bacterial driving lethal inflammatory cardiomyopathyELIGO BIOSCIENCE·Filed 2021·Granted Apr 4, 2023·0 cites·7 claims
- 2965US2023114520A1Engineered bifidobacterium strains comprising a transgeneELIGO BIOSCIENCE·Filed 2022·Application pending·0 cites
- 3063US11584781B2Chimeric receptor binding proteins resistant to proteolytic degradationELIGO BIOSCIENCE·Filed 2021·Granted Feb 21, 2023·0 cites·17 claims
- 3161US2023134572A1Chimeric receptor binding proteins resistant to proteolytic degradationELIGO BIOSCIENCE·Filed 2022·Application pending·0 cites
- 3260US2023235361A1Method of containment of nucleic acid vectors introduced in a microbiome populationELIGO BIOSCIENCE·Filed 2021·Application pending·0 cites
- 3359US2018200342A1Improving sequence-specific antimicrobials by blocking dna repairPASTEUR INSTITUT·Filed 2016·Application pending·0 cites
- 3459US2023126159A1Engineered bacterial strains comprising a transgeneELIGO BIOSCIENCE·Filed 2022·Application pending·0 cites
- 3556US2023220403A1Specific decolonization of antibiotic resistant bacteria for prophylactic purposesELIGO BIOSCIENCE·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xavier Duportet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →